We added the following clinical trials to Metastatic Trial Search for February 2025. To see all clinical trials, please visit Metastatic Trial Search.
ER or PR Positive Trials
- Estradiol Hormone Therapy and Olaparib Targeted Therapy for Postmenopausal Women with Advanced ER+, HER2- Breast Cancer
- Increasing Dose of CDK4/6 Inhibitors with Hormone Therapy to Manage Side Effects for People with Metastatic HR+, HER2- Breast Cancer
- Radioactive Drug for Advanced HR+, HER2- or Triple Negative Breast Cancer
- Abemaciclib CDK4/6 Inhibitor with Radiation for People with Metastatic HR+, HER2- Breast Cancer with Bone Metastases
- Dendritic Cell Vaccine and Hormone Therapy for Metastatic HR+, HER2- Breast Cancer with ESR1 Mutations
- Belzutifan Targeted Therapy with Hormone Therapy for Advanced ER+, HER2- Breast Cancer
- PF-07220060 CDK4 Inhibitor with Hormone Therapy for Newly Diagnosed Advanced HR+, HER2- Breast Cancer
HER2 Positive or HER2 Low Trials
- Zanidatamab Targeted Therapy for Advanced HER2 Positive Breast Cancer
- Tumor Test to Predict Response to Enhertu® for People with Metastatic HER2 Low Breast Cancer
Triple Negative Trials
- XTX301 Immunotherapy for Advanced Triple Negative Breast Cancer
- ADC, Targeted Therapy, and Stereotactic Radiation for Metastatic Triple Negative Breast Cancer with Brain Metastases
- Fermented Wheat Germ with Immunotherapy for Advanced Triple Negative Breast Cancer
- ADRX-0706 Antibody Drug Conjugate for Advanced Triple Negative Breast Cancer
Other Stage IV Trials
- DM001 Antibody Drug Conjugate for Advanced Breast Cancer
- Genomic Test Studying the Tumor Microenvironment for Advanced Breast Cancer
- Occupational Therapy to Improve Quality of Life for Stage 0-IV Breast Cancer
- MBQ-167 Targeted Therapy for Advanced Breast Cancer
- GI-102 Bispecific Antibody Alone or With Immunotherapy for Advanced Breast Cancer
- Brodalumab to Manage Immunotherapy Side Effects for People with Advanced Breast Cancer
- Screening for Brain Metastasis for People with Metastatic Breast Cancer
- ACTM-838 Bacterial Immunotherapy for Advanced Breast Cancer
Last Modified on February 3, 2025